ALK and anaplastic large cell lymphoma: It was reported that, in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphoma (ALK+ ALCL), the CRISPR/Cas9 library was used to identify molecular effectors required for PD-L1 regulation which will provide opportunities for the improvement of immunotherapeutic intervention strategies (63).